Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$375.3M
-2.1% from 2023
Prescriptions
97K
$3,870.00 per claim
Patients
10K
6,233 prescribers
Total spending, 2024
$375.5M
$36,351.79 per patient
Medicare prescription drug plans paid $375.3M for Odefsey in 2024, for 96,986 prescriptions and refills to 10,326 patients (down 2.1% from 2023). The average cost per claim was $3,870.00.
New York had the highest Medicare cost for Odefsey in 2024: $51.5M for 13,654 claims, followed by California ($49.0M).
Waref Azmeh, infectious disease in Baton Rouge, LA, had the highest Medicare cost for Odefsey in 2024: 450 claims costing $1.7M.
Odefsey is made by Gilead Sciences, Inc. (GILD), listed in the Medicare spending data as Gilead Sciences.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Waref Azmeh Baton Rouge, LA | Infectious Disease | 450 | 42 | $1.7M |
| Dong Phuong H Nguyen San Francisco, CA | Pharmacist | 111 | 33 | $1.1M |
| Heather L Hunemuller |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 6,160 | 102,919 | 10,904 | $371.6M |
| 2023 | 6,184 | 98,897 | 10,536 | $383.5M |
| 2024 | 6,233 | 96,986 | 10,326 | $375.3M |
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Nurse Practitioner |
| 266 |
| 28 |
| $964K |
| Leia M Hoang San Diego, CA | Pharmacist | 100 | 33 | $948K |
| Lucy S Ung Loma Linda, CA | Pharmacist | 106 | 30 | $926K |
| Mark E Higgins San Francisco, CA | Internal Medicine | 212 | 23 | $879K |
| Patrick Haugh Clinton, MD | Internal Medicine | 164 | 18 | $748K |
| Hector D Nieves-Vazquez Daytona Beach, FL | General Practice | 214 | 24 | $741K |
| Leonard B Berkowitz Brooklyn, NY | Infectious Disease | 191 | 28 | $740K |
| Rosa O Diring Norfolk, VA | Nurse Practitioner | 207 | 27 | $735K |
| Jennifer J Chang Los Angeles, CA | Family Practice | 81 | 26 | $730K |
| Luz A Lugo New York, NY | Infectious Disease | 204 | 27 | $726K |
| Phuong D Trinh Silver Spring, MD | Infectious Disease | 160 | 22 | $715K |
| Jyoti S Samant Montgomery, AL | Infectious Disease | 161 | 19 | $706K |
| Mary A Vogler New York, NY | Infectious Disease | 169 | 17 | $673K |
| Peter A Leahey Portland, OR | Internal Medicine | 68 | 18 | $645K |
| Frank S Rhame Minneapolis, MN | Infectious Disease | 156 | 17 | $641K |
| Ethan T Dungan Birmingham, AL | Nurse Practitioner | 156 | 18 | $632K |
| Oscar Klein New York, NY | Infectious Disease | 170 | 18 | $624K |
| David M Aboulafia Seattle, WA | Hematology-Oncology | 150 | 17 | $619K |
| Clifford A Kinder Miami, FL | Family Practice | 153 | 17 | $612K |
| Eric M Pham Santa Rosa, CA | Pharmacist | 61 | 16 | $604K |
| Christopher Lucasti Somers Point, NJ | Infectious Disease | 163 | 15 | $597K |
| Sharon D Reiley Jacksonville, FL | Nurse Practitioner | 163 | 18 | $590K |
| Michael Robinson Riverside, CA | Family Practice | 164 | 21 | $582K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Gilead Sciences GILD | 97,021 | $375.5M |